Mitochondrial DNA mutations in human tumor cells (Review)

Oncology Letters

Volumn 4, Issue 5, 2012, Pages 868-872

  Li, Hui ^a,b   Hong, Ze Hui ^a,b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Germline mutation; Mitochondrial DNA; Somatic mutation; Tumor

Indexed keywords

ADENINE; CYTOCHROME C OXIDASE; CYTOSINE; FREE RADICAL; GUANINE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; THYMINE;

APOPTOSIS; BLADDER TUMOR; BREAST TUMOR; CANCER RESEARCH; CARCINOGENESIS; CARCINOGENICITY; CELL METABOLISM; COLORECTAL TUMOR; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; ELECTROPHORESIS; ENERGY METABOLISM; ESOPHAGUS TUMOR; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GERM LINE; GLYCOLYSIS; HEAD AND NECK TUMOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INHERITANCE; LEUKEMIA; LUNG TUMOR; MOUTH CANCER; PATHOGENICITY; PHYLOGENY; POINT MUTATION; RESPIRATORY CHAIN, OXIDATIVE PHOSPHORYLATION AND CELLULAR ENERGETICS; REVIEW; SOMATIC MUTATION; STOMACH TUMOR; TUMOR CELL; TUMOR GROWTH;

EID: 84866071371     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.874     Document Type: Review

References (44)

1. Anderson S, Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature 290: 457-465, 1981.
2. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, TurnbullDM and Howell N: Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147, 1999.
3. Croteau DL and Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272: 25409-25412, 1997.
4. Yakes FM and Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94: 514-519, 1997.
5. Brown WM, George M Jr and Wilson AC: Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci USA 76: 1967-1971, 1979.
6. Cavelier L, Jazin E, Jalonen P and Gyllensten U: MtDNA substitution rate and segregation of heteroplasmy in coding and noncoding regions. Hum Genet 107: 45-50, 2000.
7. Wallace DC: Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 91: 8739-8746, 1994.
8. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
9. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
10. Eng C, Kiuru M, Fernandez MJ and Aaltonen LA: A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3: 193-202, 2003.
11. Penta JS, Johnson FM, Wachsman JT and Copeland WC: Mitochondrial DNA in human malignancy. Mutat Res 488: 119-133, 2001.
12. Habano W, Sugai T, Yoshida T and Nakamura S: Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83: 625-629, 1999.
13. Abnet CC, Huppi K, Carrera A, et al: Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer 4: 30, 2004.
14. Aikhionbare FO, Khan M, Carey D, Okoli J and Go R: Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer 3: 30, 2004.
15. Polyak K, Li Y, Zhu H, et al: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20: 291-293, 1998.
16. Fliss MS, Usadel H, Caballero OL, et al: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000.
17. Hibi K, Nakayama H, Yamazaki T, et al: Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94: 429-431, 2001.
18. Linnartz B, Anglmayer R and Zanssen S: Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res 64: 1966-1971, 2004.
19. Kumimoto H, Yamane Y, Nishimoto Y, et al: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 108: 228-231, 2004.
20. Wang CY, Li H, Hao XD, et al: Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients. PLoS One 6: e21613, 2011.
21. Wang CY, Wang HW, Yao YG, Kong QP and Zhang YP: Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121: 1253-1256, 2007.
22. Bi R, Li WL, Chen MQ, Zhu Z and Yao YG: Rapid identification of mtDNA somatic mutations in gastric cancer tissues based on the mtDNA phylogeny. Mutat Res 709-710: 15-20, 2011.
23. Beckman KB and Ames BN: Oxidative decay of DNA. J Biol Chem 272: 19633-19636, 1997.
24. Vanecek T, Vorel F and Sip M: Mitochondrial DNA D-loop hypervariable regions: Czech population data. Int J Legal Med 118: 14-18, 2004.
25. Lutz S, Weisser HJ, Heizmann J and Pollak S: Location and frequency of polymorphic positions in the mtDNA control region of individuals from Germany. Int J Legal Med 111: 67-77, 1998.
26. Stoneking M: Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet 67: 1029-1032, 2000.
27. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P and Thilly WG: High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28: 147-150, 2001.
28. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH and Kern SE: Detection of mitochondrial DNA mutations in pancreatic cancer offers a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res 61: 1299-1304, 2001.
29. Chinnery PF, Samuels DC, Elson J and Turnbull DM: Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet 360: 1323-1325, 2002.
30. Vega A, Salas A, Gamborino E, Sobrido MJ, Macaulay V and Carracedo A: mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23: 1314-1320, 2004.
31. Kloss-Brandstätter A, Schäfer G, Erhart G, et al: Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am J Hum Genet 87: 802-812, 2011.
32. Tseng LM, Yin PH, Yang CW, et al: Somatic mutations of the mitochondrial genome in human breast cancers. Genes Chromosomes Cancer 50: 800-811, 2011.
33. Dani MA, Dani SU, Lima SP, et al: Less deltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 3: 395-409, 2004.
34. Bai RK, Chang J, Yeh KT, et al: Mitochondrial DNA content varies with pathological characteristics of breast cancer. J Oncol 2011: 496189, 2011.
35. Brooks PC, Montgomery AM, Rosenfeld M, et al: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994.
36. Knighton D, Ausprunk D, Tapper D and Folkman J: Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 35: 347-356, 1977.
37. Hayashi J, Takemitsu M and Nonaka I: Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet 18: 123-129, 1992.
38. McCord JM: The evolution of free radicals and oxidative stress. Am J Med 108: 652-659, 2000.
39. Baker AM, Oberley LW and Cohen MB: Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 32: 229-233, 1997.
40. Bostwick DG, Alexander EE, Singh R, et al: Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89: 123-134, 2000.
41. Esposito LA, Melov S, Panov A, Cottrell BA and Wallace DC: Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96: 4820-4825, 1999.
42. Petros JA, Baumann AK, Ruiz-Pesini E, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724, 2005.
43. Shidara Y, Yamagata K, Kanamori T, et al: Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65: 1655-1663, 2005.
44. Verma M, Kagan J, Sidransky D and Srivastava S: Proteomic analysis of cancer-cell mitochondria. Nat Rev Cancer 3: 789-795, 2003.